• RNA Pol II Inhibition Triggers Active Apoptosis, Not Passive

  2026-04-22

  Harper et al. (2025) reveal that cell death induced by RNA Pol II inhibition results from an active apoptotic signaling pathway triggered by loss of hypophosphorylated RNA Pol IIA, rather than passive transcriptional decay. This mechanistic insight reframes approaches to DNA damage response and apoptosis research, with implications for studies employing PARP inhibitors and targeting transcription machinery.

• Caffeine (1,3,7-trimethylpurine-2,6-dione): Practical Lab Us

  2026-04-22

  Caffeine (SKU N2379) is a purine alkaloid used for in vitro and in vivo research on cancer cell inhibition, energy metabolism modulation, and neurobiology. Researchers should avoid workflows requiring ethanol solubility or long-term solution storage, and adhere strictly to product specifications for reliable results.

• Optimizing DNA Synthesis Termination with ddATP (2',3'-dideo

  2026-04-21

  This article presents scenario-driven strategies for deploying ddATP (2',3'-dideoxyadenosine triphosphate), specifically SKU B8136, in cell-based assays, DNA repair studies, and nucleic acid workflow improvements. Integrating recent literature and practical lab perspectives, we demonstrate how APExBIO's ddATP supports reproducible, sensitive experimental design and reliable protocol execution.

• Melittin as a Bioactive Peptide: Signal Modulator in Cancer

  2026-04-21

  Melittin, a potent bioactive peptide from APExBIO, offers unique dual-action modulation of G protein signaling, enabling precise dissection of apoptosis and cancer cell signaling pathways. This article translates cutting-edge glioblastoma research into actionable laboratory workflows, with practical troubleshooting tips for maximizing reproducibility and data quality.

• PYR-41: Advancing E1 Ubiquitin Enzyme Inhibition in Translat

  2026-04-20

  This article explores the frontiers of E1 enzyme inhibition with PYR-41, integrating mechanistic insights from the ubiquitin-proteasome system, noncanonical NF-κB pathway modulation, and recent cancer immunology advances. Strategic guidance is provided for translational researchers aiming to harness PYR-41 in inflammation, apoptosis, and cancer models, with a critical synthesis of new literature and rigorous protocol recommendations.

• Quercetin Modulates Hippo Pathway to Protect Cataract Lenses

  2026-04-20

  This study identifies quercetin as a potent modulator of the Hippo signaling pathway, demonstrating its ability to protect against cataract formation by reducing oxidative stress and promoting lens epithelial cell survival. The findings provide mechanistic insight into non-surgical cataract interventions and highlight the Hippo pathway as a promising therapeutic target.

• Streptavidin-Cy3: Quantitative Fluorescence for Biotin Assay

  2026-04-19

  Discover the advanced quantitative advantages of Streptavidin-Cy3 in biotin detection assays. This deep dive explores fluorescence dynamics, workflow optimization, and recent cancer research applications, offering a practical, evidence-driven guide for next-generation immunohistochemistry and immunofluorescence.

• Dihydroethidium: Precision Superoxide Detection in Oxidative

  2026-04-18

  Dihydroethidium (DHE) stands out as a robust, cell-permeable probe for quantifying intracellular superoxide, enabling high-sensitivity oxidative stress and apoptosis research. This guide translates cutting-edge findings and hands-on workflow enhancements into actionable protocols, with troubleshooting tips to ensure reproducibility across cardiovascular and cancer models.

• High-Throughput BBB Permeability Prediction via Surrogate Mo

  2026-04-17

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction to predict CNS drug permeability. The model offers strong correlation with in vivo brain distribution, supporting early-stage CNS drug screening.

• OM-MSCs Mitigate Golgi Stress via PEDF-PI3K/Akt/mTOR in Stro

  2026-04-16

  This study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus stress after cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR pathway. These findings support novel neuroprotective strategies targeting intracellular stress responses in ischemic stroke.

• Bedaquiline: Advanced Mechanistic Insights and Assay Guidanc

  2026-04-15

  Explore how bedaquiline, a diarylquinoline antibiotic, disrupts Mycobacterium tuberculosis energy metabolism and impairs cancer stem cells. This article delivers advanced practical guidance and unique assay considerations for researchers, setting it apart from existing resources.

• Ziprasidone HCl: Nanocrystal-Driven Permeability and Antitum

  2026-04-14

  Explore how Ziprasidone Hydrochloride (Ziprasidone HCl) nanocrystal technology advances dopaminergic and serotonergic research. This article delivers unique insight into permeability, assay design, and antitumor applications, with protocols and translational perspectives.

• Antipyrine in CNS Drug Research: Solubility, Permeability, a

  2026-04-13

  Explore the role of Antipyrine as a benchmark compound in CNS drug research, with deep insight into its solubility, permeability, and use in modern blood-brain barrier assays. This article provides a unique, evidence-based perspective on 1,5-dimethyl-2-phenylpyrazol-3-one for advanced pharmacokinetic studies.

• Dovitinib (TKI-258): Advanced RTK Inhibition in Signal Trans

  2026-04-13

  Explore the unique multitargeted mechanism of Dovitinib (TKI-258) in modulating ERK and STAT pathways for apoptosis induction in cancer cells. This comprehensive guide offers original analysis, protocol insights, and key practical takeaways for advanced oncology research.

• Tamoxifen as a Selective Estrogen Receptor Modulator in Benc

  2026-04-12

  Tamoxifen empowers researchers with its dual action as an estrogen receptor antagonist and a versatile tool for gene knockout, kinase inhibition, and antiviral assays. This guide details protocol optimization, troubleshooting, and practical advances, leveraging APExBIO's high-purity formulation to ensure reproducible outcomes from cancer biology to CreER-mediated gene knockout studies.

15694 records 1/1047 page Next 12345 下5页 Last page